Arcadia Biosciences (RKDA) Assets Average (2016 - 2025)
Arcadia Biosciences (RKDA) has disclosed Assets Average for 11 consecutive years, with $8.2 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Assets Average fell 49.79% year-over-year to $8.2 million, compared with a TTM value of $8.2 million through Sep 2025, down 49.79%, and an annual FY2024 reading of $16.6 million, down 31.68% over the prior year.
- Assets Average was $8.2 million for Q3 2025 at Arcadia Biosciences, down from $10.4 million in the prior quarter.
- Across five years, Assets Average topped out at $70.8 million in Q2 2021 and bottomed at $8.2 million in Q3 2025.
- Average Assets Average over 5 years is $31.2 million, with a median of $28.6 million recorded in 2023.
- The sharpest move saw Assets Average surged 102.21% in 2021, then tumbled 49.79% in 2025.
- Year by year, Assets Average stood at $51.6 million in 2021, then crashed by 38.54% to $31.7 million in 2022, then tumbled by 31.9% to $21.6 million in 2023, then crashed by 33.39% to $14.4 million in 2024, then tumbled by 43.07% to $8.2 million in 2025.
- Business Quant data shows Assets Average for RKDA at $8.2 million in Q3 2025, $10.4 million in Q2 2025, and $13.3 million in Q1 2025.